Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Adjuvanted cell-derived, inactivated novel swine origin A/H1N1 monovalent subunit influenza virus vaccine · 2 trials · 2 indications
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | Dose ranging |
| 2 | EXPERIMENTAL | Dose ranging |
| Arm 1 | OTHER | Dose ranging |
| Arm 2 | OTHER | Dose ranging |
| Name | Type | Description |
|---|---|---|
| Adjuvanted cell-derived, inactivated novel swine origin A/H1N1 monovalent subunit influenza virus vaccine | BIOLOGICAL | High dose group and low dose group of adjuvanted vaccines |
Inclusion Criteria: * Healthy Japanese aged 6 months to 19 years Exclusion Criteria: * History of anaphylaxis, serious vaccine reactions, hypersensitivity to vaccine viral proteins or excipients * Administration of adjuvanted influenza vaccine or suspected influenza disease within 3 month prior t...